Divis Laboratories Ltd | DIVI - Cash And Equivalent

Stock Price
5,861.00
Daily Change
40.00 0.69%
Monthly
-7.41%
Yearly
8.79%
Q2 Forecast
5,728.83

Divis Laboratories Ltd reported INR4.15B in Cash and Equivalent for its fiscal quarter ending in March of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Aurobindo Pharma INR 88.91B 6.56B Sep/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Lupin INR 30.4B 1.02B Sep/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Tilray USD 264.83M 43.16M Jun/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025